Icariin

DB12052InvestigationalSmall molecule

Icariin has been investigated for the basic science of the Pharmacokinetic Profile of Icariin in Humans.

Chemical structure of Icariin
Formula / weight
C33H40O15 · 676.668 g/mol (avg)

Resolves to

Compound
UNIIVNM47R2QSQCAS489-32-7ChEMBLCHEMBL553204ChEBI78420PubChem5318997KEGGC17555
Clinical / RWD
RxNorm1788871
Structure
InChIKeyTZJALUIVHRYQQB-XLRXWWTNSA-NSMILESCOC1=CC=C(C=C1)C1=C(O[C@@H]2O[C@@H](C)[C@H](O)[C@@H](O)[C@H]2O)C(=O)C2=C(O)C=C(O[C@@H]3O[C@H](CO)[C@@H](O)[C@H](O)[C@H]3O)C(CC=C(C)C)=C2O1
Targets
O76074PDE5A

What you can answer from here — as of April 02, 2025

1Protein targetEach mapped to UniProt, with action and pharmacological action
Listed above
4Clinical trialsPhase, status and sponsor resolved per trial
Sign in
1+ReferenceStructured and connected to the statements they support
Sign in

Which drugs share a target with Icariin, and which of those have an active Phase 3 trial?

Answer this in Biopharma OSSign in to your account

Create a free account or log in to explore the full data card.

Create Account
Log InPaid Account Log In